E. Brain

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

R. Gelber, A. Tutt, M. Piccart, 2023, The Lancet.

Cancer mortality and competing causes of death in older adults with cancer: A prospective, multicentre cohort study (ELCAPA‐19)

F. Canouï-Poitrine, M. Laurent, M. Frelaut, 2023, Cancer medicine.

Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

H. Wildiers, S. Kuemmel, J. Huober, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET.

R. Wuerstlein, M. Palleschi, A. De Censi, 2024, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of guideline adherence and expert center referral on the early management and outcomes of uterine sarcoma patients: A retrospective analysis from the French NETSARC network.

S. Piperno-Neumann, E. Laas, A. Hamy, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.

M. Mouret-Reynier, C. Kaderbhai, C. Jouannaud, 2024, European journal of cancer.

Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis

F. Bidard, M. Sablin, P. Cottu, 2024, Oncogene.

Overall Survival With Circulating Tumor Cell Count–Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial

F. Bidard, V. Diéras, F. Dalenc, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort.

F. Dalenc, T. Bachelot, M. Arnedos, 2023, European journal of cancer.

Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative.

H. Wildiers, M. Mauer, S. Mohile, 2023, Journal of geriatric oncology.

Alterations in comprehensive geriatric assessment decrease survival of elderly patients with cancer.

K. Leffondré, P. Feugier, S. Mathoulin-Pélissier, 2018, European journal of cancer.

Adequate assessment yields appropriate care-the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group.

R. Kanesvaran, J. Krok-Schoen, G. Liposits, 2024, ESMO open.

Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study

M. Laurent, P. Caillet, M. Bringuier, 2023, ESMO open.